RBC Capital lowered the firm’s price target on Inovio (INO) to $5 from $6 and keeps a Sector Perform rating on the shares. The company ...

Inovio Pharmaceuticals (NASDAQ:INO – Free Report) had its target price lowered by Royal Bank of Canada from $6.00 to $5.00 in a research report sent to investors on Wednesday,Benzinga reports. The ...

Inovio plans to begin submitting the BLA for INO-3107 in mid-2025, with a goal of achieving FDA acceptance for filing by year-end 2025. Priority review will also be requested.

Oasis Management Company Ltd. ("Oasis") is the manager to funds that beneficially own approximately 11.5% of Japan ink and chemical products manufacturer DIC Corporation (4631 JT) ("DIC" or the ...

Stay updated on market trends for INO. Shares of Inovio Pharmaceuticals pulled back by 5.3% during Wednesday's session. The decline may be attributed to profit-taking, as investors assess renewed ...

Legacy EV is the market leader in EV adoption, providing fully integrated EV systems, certified technician training, and EV design consultation. By offering innovative education programs like the EV ...

Naruto is filled with powerful emotional moments that tug at the heartstrings, showcasing the deep bonds that define the ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

I f there is one thing Naruto is beloved for and remembered for even a decade after it ended, it is the amount of amazing side characters it blessed fans with, and one of the most ...

At the event, to be held at the SPI Innovation Theatre on 3-5 June 2025 at Messe Essen, Germany, speakers will unveil ...